Esther Landesman, PhD
Instructor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Hematology & Medical Oncology

PhD, Boston University
MS, The Hebrew University of Jerusalem
BS, The Hebrew University of Jerusalem



Dr. Landesman's research has focused on studying the role of protein kinase CK2, a highly conserved and constitutively expressed serine-threonine kinase. In vitro and transgenic mouse models were used to study the role of CK2 in breast tumorigenesis and the synergism of CK2 with the absence of p53 in lymphoma development. Genetic disruption of the catalytic subunits of CK2: CK2a and CK2a’ have uncovered the impact of CK2 in mouse embryonic development. Current research attempts to characterize the consequences of compounded reduction of CK2 catalytic subunits in mice. Dr. Landesman-Bollag obtained her PhD and did her postdoctoral training at Chobanian and Avedisian School of Medicine in the laboratory of the late Dr. David Seldin. She is Instructor of Hematology & Medical Oncology at Chobanian and Avedisian School of Medicine.



The Role of an Environmental Chemical Receptor in Development and Propagation of Cancer St..
07/01/2014 - 12/31/2016 (PI)
Trustees of Boston University Avon Foundation

Breast Cancer Research
01/03/2000 - 12/31/2002 (PI)
DPH


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Zhou Y, Lian H, Shen N, Korm S, Kwok Ping Lam A, Layton O, Huiting LN, Li D, Miao K, Zeng A, Landesman-Bollag E, Seldin DC, Fu H, Hong L, Feng H. The multifaceted role of protein kinase CK2 in high-risk acute lymphoblastic leukemia. Haematologica. 2021 05 01; 106(5):1461-1465.View Related Profiles. PMID: 32817283; PMCID: PMC8094085; DOI: 10.3324/haematol.2020.246918;
     
  2. Lian H, Li D, Zhou Y, Landesman-Bollag E, Zhang G, Anderson NM, Tang KC, Roderick JE, Kelliher MA, Seldin DC, Fu H, Feng H. CK2 inhibitor CX-4945 destabilizes NOTCH1 and synergizes with JQ1 against human T-acute lymphoblastic leukemic cells. Haematologica. 2017 01; 102(1):e17-e21.View Related Profiles. PMID: 27758824; PMCID: PMC5210253; DOI: 10.3324/haematol.2016.154013;
     
  3. Novikov O, Wang Z, Stanford EA, Parks AJ, Ramirez-Cardenas A, Landesman E, Laklouk I, Sarita-Reyes C, Gusenleitner D, Li A, Monti S, Manteiga S, Lee K, Sherr DH. An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells. Mol Pharmacol. 2016 Nov; 90(5):674-688.View Related Profiles. PMID: 27573671; PMCID: PMC5074452; DOI: 10.1124/mol.116.105361;
     
  4. Stanford EA, Wang Z, Novikov O, Mulas F, Landesman-Bollag E, Monti S, Smith BW, Seldin DC, Murphy GJ, Sherr DH. The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells. BMC Biol. 2016 Mar 16; 14:20.View Related Profiles. PMID: 26984638; PMCID: PMC4794823; DOI: 10.1186/s12915-016-0240-y;
     
  5. Romagnoli M, Belguise K, Yu Z, Wang X, Landesman-Bollag E, Seldin DC, Chalbos D, Barillé-Nion S, Jézéquel P, Seldin ML, Sonenshein GE. Epithelial-to-mesenchymal transition induced by TGF-ß1 is mediated by Blimp-1-dependent repression of BMP-5. Cancer Res. 2012 Dec 1; 72(23):6268-78.View Related Profiles. PMID: 23054396; PMCID: PMC3513653; DOI: 10.1158/0008-5472.CAN-12-2270;
     
  6. Landesman-Bollag E, Belkina A, Hovey B, Connors E, Cox C, Seldin DC. Developmental and growth defects in mice with combined deficiency of CK2 catalytic genes. Mol Cell Biochem. 2011 Oct; 356(1-2):227-31.View Related Profiles. PMID: 21769451; PMCID: PMC3397194; DOI: 10.1007/s11010-011-0967-2;
     
  7. Seldin DC, Lou DY, Toselli P, Landesman-Bollag E, Dominguez I. Gene targeting of CK2 catalytic subunits. Mol Cell Biochem. 2008 Sep; 316(1-2):141-7.View Related Profiles. PMID: 18594950; PMCID: PMC3696998; DOI: 10.1007/s11010-008-9811-8;
     
  8. Lou DY, Dominguez I, Toselli P, Landesman-Bollag E, O'Brien C, Seldin DC. The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development. Mol Cell Biol. 2008 Jan; 28(1):131-9.View Related Profiles. PMID: 17954558; PMCID: PMC2223292; DOI: 10.1128/MCB.01119-07;
     
  9. Eddy SF, Guo S, Demicco EG, Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Sonenshein GE. Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells. Cancer Res. 2005 Dec 15; 65(24):11375-83.View Related Profiles. PMID: 16357145
     
  10. Demicco EG, Kavanagh KT, Romieu-Mourez R, Wang X, Shin SR, Landesman-Bollag E, Seldin DC, Sonenshein GE. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland. Mol Cell Biol. 2005 Nov; 25(22):10136-47.View Related Profiles. PMID: 16260626; PMCID: PMC1280249; DOI: 10.1128/MCB.25.22.10136-10147.2005;
     
Showing 10 of 27 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 23 publications over 13 distinct years, with a maximum of 4 publications in 2005

YearPublications
19982
19991
20001
20013
20023
20031
20054
20071
20081
20111
20121
20163
20211


Available to Mentor as: (Review Mentor Role Definitions):
  • Project Mentor
Contact for Mentoring:

820 Harrison Ave
Boston MA 02118
Google Map

617.638.7012
Download vCard

Landesman's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (218) concept(s)
_
Co-Authors
See all (19) people
_
Similar People
See all (60) people
_
Same Department
Search Department